Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. We thank Zheng Fu and Fulei ...

Joshua Short is a 4-time Emmy Award-winning broadcast journalist, from Chicago, Illinois. Not far from where he was raised in the Windy City is where he grew up professionally. He moved to the area in ...

New discoveries, everyday mysteries, and the science behind the headlines — in just under 15 minutes. It's science for everyone, using a lot of creativity and a little humor. Join hosts Emily Kwong ...

It's tough to stand out among the deluge of activewear brands on IG, but you might’ve noticed these shorts—either on your feed or in your gym—with a giant white X on the back. Those are Ten Thousand's ...

Les Masterson is a deputy editor and insurance analyst at Forbes Advisor. He has been a journalist, reporter, editor and content creator for more than 25 years. He has covered insurance for a decade, ...

For decades, Martin Short has kept audiences laughing with his sharp humor and unforgettable characters. But behind the comedy icon was a deeply personal love story with his late wife, Canadian ...

The actor welcomed three kids with his late wife Nancy Dolman Francesca Gariano is a contributing writer at PEOPLE. She has been working at PEOPLE since 2022. Her work has previously appeared in TODAY ...

Tom Colicchio's braised short ribs are meltingly tender and marinated in red wine for a rich sauce. They're fabulous over mashed potatoes or buttered noodles. Tom Colicchio is the chef and owner of ...

Relacorilant, a selective glucocorticoid receptor modulator, provides sustained blood pressure control and metabolic benefits in patients with Cushing syndrome, according to a phase 3 trial.

SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on ...

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced earnings with reported revenue of $243.8 million for Q4 2025, representing 21% year-over-year revenue growth for WAKIX(R) . For the ...